Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.04. | BrightSpring Health Services, Inc. TANGIBLE EQUITY UNIT declares $0.843 dividend | 2 | Seeking Alpha | ||
10.04. | BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025 | 3 | GlobeNewswire (USA) | ||
31.03. | BrightSpring Health Services (BTSG): Among Top High-Risk, High-Reward Growth Stocks To Buy Now | 1 | Insider Monkey | ||
06.03. | BrightSpring Health Services, Inc. - 10-K, Annual Report | - | SEC Filings | ||
06.03. | BrightSpring Health Services, Inc. Q4 Earnings Summary | - | RTTNews | ||
06.03. | BrightSpring Health Services beats top-line and bottom-line estimates; raises FY25 outlook | 1 | Seeking Alpha | ||
BRIGHTSPRING HEALTH SERVICES Aktie jetzt für 0€ handeln | |||||
06.03. | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance | 377 | GlobeNewswire (Europe) | LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
05.03. | BrightSpring Health Services announces promotion of Jennifer Phipps to CFO | 1 | Seeking Alpha | ||
05.03. | BrightSpring Health Services, Inc. Announces Promotion of Jennifer Phipps to Chief Financial Officer | 158 | GlobeNewswire (Europe) | LOUISVILLE, Ky., March 05, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG) a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
05.03. | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
05.03. | BrightSpring Health Services: Finanzielle Erholung und Wachstumserwartungen | 2 | IT BOLTWISE | ||
22.02. | BrightSpring Health Services, Inc. (BTSG): Among the Hot New Stocks to Buy Now | 2 | Insider Monkey | ||
14.02. | BrightSpring Health Services, Inc. (BTSG): Among the Health Information Services Stocks Outpacing the Market in 2025 | 3 | Insider Monkey | ||
02.02. | Why BrightSpring Health Services, Inc. (BTSG) Is Among the Best Booming Stocks to Invest in Now? | 2 | Insider Monkey | ||
29.01. | The Analyst Verdict: BrightSpring Health In The Eyes Of 7 Experts | 2 | Benzinga.com | ||
27.01. | Brightspring Health stock hits all-time high at $81.03 | 2 | Investing.com | ||
27.01. | Brightspring Health stock soars to all-time high of $22.97 | 1 | Investing.com | ||
21.01. | BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities | 3 | Benzinga.com | ||
21.01. | BrightSpring Health stock rises on divestiture plan | 1 | Investing.com | ||
21.01. | BrightSpring Health-Aktie steigt nach Ankündigung von Veräußerungsplan | 2 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 71,60 | -1,42 % | Medtronic Gets FDA Approval For Simplera Sync Sensor For MiniMed 780G System | WASHINGTON (dpa-AFX) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system.The MiniMed 780G system... ► Artikel lesen | |
INTUITIVE SURGICAL | 410,05 | -3,36 % | Intuitive Surgical Q1 2025 Earnings Preview | ||
THERMO FISHER | 370,50 | -1,44 % | $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today | ||
ROKU | 52,32 | +1,81 % | Benchmark maintains Roku stock Buy rating, $130 target | ||
BECTON DICKINSON | 172,95 | -1,00 % | BD Unveils HemoSphere Alta Advanced Monitoring Platform | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) has launched HemoSphere Alta Advanced Monitoring Platform with predictive, artificial intelligence based algorithms that can help clinicians... ► Artikel lesen | |
DEXCOM | 58,50 | -3,00 % | Dexcom G7 zur kontinuierlichen Glukosemessung in Echtzeit jetzt in der Schweiz mit Omnipod® 5 kompatibel | HORW (ots) - Dexcom, der weltweit führende Anbieter von Systemen zur kontinuierlichen Glukosemessung in Echtzeit für Menschen mit Diabetes, gab heute bekannt, dass sein leistungsstärkstes System für... ► Artikel lesen | |
RESMED | 182,95 | -2,30 % | Resmed, Inc.: Resmed Names Salli Schwartz as Chief Investor Relations Officer | Former Illumina, MSCI, and Moody's executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX:... ► Artikel lesen | |
DAVITA | 115,15 | -7,88 % | DaVita-occupied data center up for sale in Tacoma, Washington | ||
ATOSSA THERAPEUTICS | 0,540 | -1,46 % | Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer | CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM)... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
GE HEALTHCARE TECHNOLOGIES | 53,09 | -3,17 % | What to Expect From GE HealthCare's Next Quarterly Earnings Report | ||
ORGANON | 9,496 | -2,82 % | Organon erweitert Vorstand mit neuer Direktorin von Takeda | ||
TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP | BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
QUIDELORTHO | 21,800 | -1,80 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
VERU | 0,460 | -2,38 % | Veru Aktie: Bedeutet das eine Neuausrichtung? | Die Veru-Aktie verliert weiter an Wert, doch Analysten bleiben optimistisch aufgrund vielversprechender Medikamentenentwicklungen. Wird der Tiefpunkt bald erreicht? Die Veru-Aktie setzt ihre Abwärtsspirale... ► Artikel lesen |